Is There A Smart Way To Use The New Oncotype Prostate Cancer Test?
On May 8th, the makers of the oncotype DX Prostate Cancer Test presented results of a large study demonstrating that their test can help men decide whether their prostate cancer carries a low enough risk of progression to forgo surgical or radiation therapy, two treatments that typically eradicate prostate cancers but also cause most men to experience impotence and incontinence.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Peter Ubel Source Type: news
More News: Cancer | Cancer & Oncology | Impotence | Incontinence | Pharmaceuticals | Prostate Cancer | Radiation Therapy | Study